acrwas basically sat on at 1.40 by QIC and has been sold...

acr
was basically sat on at 1.40 by QIC and has been sold down
through the crisis by them and others resulting in them finally selling out at 45c to a melb fund.
since then the company has languished at 60ish due to the problems of its US marketing partner KV.
to me this was somewhat of a furfie as they continued to market and sell the product.
to me the real value of the pipeline lies in the axiron product which has been doing well in the background in recent times.
with the overhang gone and the sector picking up i feel that someone has determined that this company is seriously undervalued and begun to accumulate.
the volume has been substantial not moderate and i beleive this buyer/buying has been heightened by the recent ann that two of ACR competitors in the testosterone space have been issued "black box" warnings adding further value to the company and urgency to the buying.
that said i am surprised by the snowballing volume and wouldnt be surprised if a significant ann was to follow.
with overhang gone this thing could really motor on news
wtahc for break 1.40 to 1.75